Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 39,000 shares at $8.44 ($325K) on 2017-05-18, disclosed to the SEC on 2017-05-19.
Open-market sale of $325k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.44 | 9,000 | $76K | 23.4% |
| 2 | $8.31 | 15,000 | $125K | 38.3% |
| 3 | $8.31 | 15,000 | $125K | 38.3% |
| Total | $8.34 avg | 39,000 | $325K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |